The initiating sensor differs by species: human cells use caspases-4 and -5, whereas mouse cells use caspase-11. These inflammatory caspases recognize cytosolic LPS and then cleave gasdermin D. This distinction is important when interpreting experiments or translating findings between human and mouse models, because the corresponding caspase components are not identical.
Gasdermin D provides the direct link between inflammatory caspase activation and membrane damage. After cleavage, it forms pores in the cell membrane, producing the structural change associated with pyroptosis. This event can cause cell death and release inflammatory signals, so gasdermin D functions as a central effector rather than merely an upstream sensor of bacterial material.
Potassium efflux connects the initial cytosolic LPS response to activation of the NLRP3 inflammasome. This secondary step expands the inflammatory output beyond pore formation and pyroptotic death by promoting maturation of interleukin-1β and interleukin-18. Consequently, the pathway can combine rapid cellular disruption with production of mature inflammatory cytokines.
Engagement can be understood through a sequence of linked outcomes: inflammatory caspase activity, gasdermin D cleavage, membrane pore formation, pyroptotic cell death, potassium efflux, and NLRP3-dependent cytokine maturation. Considering these events together helps distinguish the initial cytosolic LPS response from its downstream consequences, including release of inflammatory signals and mature interleukin-1β or interleukin-18.
Gram-negative bacterial infection can place LPS inside the cytosol, where it is detected by the species-specific inflammatory caspases described above. Subsequent gasdermin D pore formation and pyroptotic death help generate an inflammatory response to the infection. Studying this sequence clarifies how intracellular sensing of a bacterial component contributes to host defense.
The same signaling events that support protection against infection can also produce excessive inflammation when poorly controlled. Because the pathway drives pyroptotic death, inflammatory signal release, and maturation of interleukin-1β and interleukin-18, it provides a framework for investigating sepsis and autoinflammatory disease. It also supports research into strategies designed to regulate excessive inflammatory responses.